Charleston, SC -- (SBWIRE) -- 09/20/2013 -- The Team of advisers at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer. Have a look at: Cereplast Inc (OTCMKTS:CERP), New Energy Technologies Inc (OTCMKTS:NENE), Decision Diagnostics Corp (OTCBB:DECN), Cannabis Science Inc (OTCMKTS:CBIS)
Cereplast Inc (OTCMKTS:CERP) increased +4.29% and closed at $0.0146 on a traded volume of 9.42 million shares, in comparison to 18.89 million shares of average trading volume. So far this year, the stock is down over -50.51%.
The company has a total market capitalization of $10.52 million and its total outstanding shares are 720.22 million. Cereplast, Inc. develops and commercializes bio-based resins. It provides Cereplast Compostables resins, which are compostable, bio-based, and ecologically sound substitutes for petroleum-based plastics targeting compostable bags, single-use food service products, and packaging applications.
For How Long CERP will Fight for Profitability? Read This Trend Analysis report
New Energy Technologies Inc (OTCMKTS:NENE) soared +1.33% and closed at $2.28 on a traded volume of 156,670 shares, whereas its average trading volume is 73,523 shares. In the last three months, the stock is up +9.62%. The Intra-day range for the stock is $2.17 and $2.35.
New Energy Technologies, Inc. operates as a development stage renewable and alternative energy company. It develops SolarWindow electricity generating system, which facilitates to harvest light energy from the sun and artificial sources.
Will NENE Continue To Move Higher? Find Out Here
Decision Diagnostics Corp (OTCBB:DECN) dropped down -5.57% and closed at $0.680. So far in three months, the stock is up +195.65%. The 52-week range for the stock is $0.06 and $0.75 and during the previous trading session the stock touched its highest price at $0.75. Its introductory price for the day was $0.74, with the overall traded volume of 455,834 shares.
Decision Diagnostics Corp. distributes prescription and non-prescription diagnostics, and home testing products in the United States. The company provides bulk prescription drugs on a wholesale basis; and distributes diabetes diagnostics and supplies.
Has DECN Found The Bottom and Ready To Move Up? Find Out Here
Cannabis Science Inc (OTCMKTS:CBIS), after opening its shares at the price of $0.05, jumped up +0.65% to close at $0.0466 for the day. The stock moved on a traded volume of 2.54 million shares, in comparison to 2.97 million shares of average trading volume.
The 52-week range for the stock is $0.03 and $0.12 and during the previous trading session the stock touched its highest price at $0.05. Its introductory price for the day was $0.05. Cannabis Science, Inc., a development stage company, engages in the development, production, and commercialization of phytocannabinoid-based pharmaceutical products.
For How Long CBIS’s Gloss will Attract Investors? Find out via this report
Our team of advisers here at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the CapitalEquityReport.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
Read Full Disclaimer at: http://capitalequityreport.com/about-us/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)